Looking to publish in Molecular Diagnosis & Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginMolecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine. The journal publishes reviews and original research articles focused on linking diagnostic and prognostic biomarkers to appropriate therapy, with an emphasis on companion diagnostic and therapeutic products, pharmacogenomic data for drug development, and therapeutic decision making.
Looking to publish in Molecular Diagnosis & Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Molecular Diagnosis & Therapy accepts the following article types. Click on an article type to view submission instructions.
Review Article
Systematic Review
Original Research
Letter To The Editor
Recent Publications
Analytical and Clinical Validation of the Oncomine Dx Express Test, an In Vitro Diagnostic-Labeled Assay, for Genomic Profiling of FFPE Tumor Samples
Angie Cheng, Sumitha Nallu, Luming He, April Bigley, Aline Bridi, Emilia Ostrowska, Thilanka Jayaweera, Madhu Jasti, Daniela Garcia, Molly Fehon, Thomas Bowden, Nader Ezzedine, Diarra Hassel, Swasti Raut, Erik Breitenfeldt, Alina Dykman, Tasha Delacour, Brian Hradecky, Andrew Hatch, Stephen Wunsch, Gokhan Yavas, Del Rodrigo, Jeoffrey Schageman, Elena Kuzmenko, Jessie Wang, Vrunda Sheth, Eun Ji Kim, Hsueh Ping Chao, John Williamson, Hans Gripkey, José Luis Costa, Cecília Durães, Anne Marie Velasco Roth
Manganese-Enhanced Magnetic Resonance Imaging: From Translational Research to First-in-Human Trials in Oncology
Piotr Remiszewski, Monika A. Drabik, Paulina Filipowicz, Marlena Wełniak-Kamińska, Kacper J. Piwowarek, Michał Wieteska, Michał Fiedorowicz, Anna M. Czarnecka
Development of Diagnostic Models and Biomarker Identification for Type 1 Leptomeningeal Metastasis in Lung Adenocarcinoma Using Olink: Exploratory Cohort Study with Internal Temporal Validation
Peng Ding, Qiuchi Chen, Yun Li, Yulan Kui, Zhi Wang, Hongxia Zhou, Bohua Kuang, Lingjuan Chen, Xing Zhang, Minghui Ge, Tiantian Han, Ruiguang Zhang, Fan Tong, Xiaorong Dong
Comparison of Maxwell Kit-Based and NaOH-Based DNA Extraction Incorporated copro-DNA-SjTR1-qPCR Systems: Insights from Detecting Low-Intensity Schistosoma Japonicum Infections
Emmanuel John Tabilin, Catherine A. Gordon, Mario A. Jiz, Eleonor Avenido-Cervantes, Marianette Inobaya, Marcello Otake Sato, Megumi Sato, Yasuhito Sako, Darren J. Gray, Mary Lorraine Mationg, Yi Mu, Pengfei Cai
Population Reference Data in the Molecular Diagnosis of Pathogenic CAPN3 Variants: Contextual Evidence and Interpretive Limits
Meghan H. Carr, Ehab Y. Harahsheh, Shaymaa Shurrab, Bukola A. Olarewaju, Mayowa A. Osundiji
Frequently asked questions
How long does it take to publish?
Submission to first decision (median): 7 days.
Reformat to Molecular Diagnosis & Therapy using Livewrite PremiumIs a cover letter required?
A submission letter is referenced for reviewer suggestions, and the corresponding author should mention any unpublished material included in the manuscript in a cover letter to the Editor.
Reformat to Molecular Diagnosis & Therapy using Livewrite PremiumWhat are the publication costs?
No charge for the traditional subscription-based publishing route; optional open access publication is available for accepted articles.
Reformat to Molecular Diagnosis & Therapy using Livewrite Premium